Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-18

Clinical Trial Update: Efficacy Of Autologous Epidermal Cell Suspension And Silver Sulfadiazine Ointment In Burn [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating autologous epidermal cell suspension with silver sulfadiazine ointment for burn treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: SCARM Institute, Tabriz, Iran | Conditions: Burn | Phase 2 | Status: COMPLETED